Gemals, a new drug candidate, extends lifespan and improves electromyographic parameters in a rat model of amyotrophic lateral sclerosis

References

• Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62
   PubMed Web of Science ®Google Scholar
• Nagai M., Re D. B., Nagata T., Chalazonitis A., Jessell T. M., Wichterle H., et al. Astrocytes expressing ALS‐linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007; 10: 615–22
   PubMed Web of Science ®Google Scholar
• Howland D. S., Liu J., She Y., Goad B., Maragakis N. J., Kim B., et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant mediated amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2002; 99: 1604–9
   PubMed Web of Science ®Google Scholar
• Philippeau M., Manto M., Sokolow S., Laute M. A., Brion J. P., Pandolfo M., et al. Recent advances in transgenic models of ALS: electrophysiological, morphological and neurochemical characterization of hSOD‐1 G93A transgenic rats. Recent Research Developments in Physiology 2005; 3: 13–31
   Google Scholar
• Carri M. T., Grignashi G., Bendotti C. Targets in ALS: designing multi‐drug therapies. Trends Pharmacol Sci 2006; 27: 267–73
   PubMed Web of Science ®Google Scholar
• Mangas A., Covenas R., Bodet D., Dabadie M. P., Glaize G., Geffard M. Evaluation of the effects of a new drug on brain leukocyte infiltration in an experimental model of autoimmune encephalomyelitis. Letters in Drug Design & Discovery 2006; 3: 138–48
   Web of Science ®Google Scholar
• Pimm M. V., Hudecz F. Biodistribution in tumour‐bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly‐L‐lysine backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteins. J Cancer Res Clin Oncol 1996; 122: 45–54
   PubMedGoogle Scholar
• Ali M., Hicks A. E., Hellewell P. G., Thoma G., Norman K. E. Polymers bearing sLex mimetics are superior inhibitors of E‐selectin‐dependent leukocyte rolling in vivo. FASEB J 2004; 18: 152–4
   PubMedGoogle Scholar
• Daube J. R. Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle Nerve 2000; 23: 1488–502
   PubMed Web of Science ®Google Scholar
• Blondeau N., Widmann C., Lazdunski M., Heurteaux C. Polyunsaturated fatty acids induce ischaemic and epileptic tolerance. Neuroscience 2002; 109: 231–41
   PubMed Web of Science ®Google Scholar
• Yoshida H., Yanai H., Namiki Y., Fukatsu‐Sasaki K., Furutani N., Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006; 12: 9–20
   PubMedGoogle Scholar
• Agar J., Durham H. Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 232–42
   PubMed Web of Science ®Google Scholar
• Salauze L., van der Velden C., Lagroye I., Veyret B., Geffard M. Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients. Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6: 226–33
   PubMed Web of Science ®Google Scholar
• Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E. B., et al. Familial ALS‐superoxide dismutases associate with mitochondria and shift their redox potentials. Proc Natl Acad Sci U S A 2006; 103: 13860–5
   PubMed Web of Science ®Google Scholar
• Ward R., Cirkovic‐Vellichovia T., Ledeque F., Tirizitis G., Dubars G., Datla K., et al. Neuroprotection by taurine and taurine analogues. Adv Exp Med Biol 2006; 583: 299–306
   PubMedGoogle Scholar
• El Idrissi A. Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 2008; 34: 321–8
   PubMed Web of Science ®Google Scholar
• Crouzin N., De Jesus Ferreira M. C., Cohen‐Solal C., Aimar R. F., Vignes M., Guiramand J. Alpha‐tocopherol‐mediated long‐lasting protection against oxidative damage involves an attenuation of calcium entry through TRP‐like channels in cultured hippocampal neurons. Free Radic Biol Med 2007; 42: 1326–37
   PubMed Web of Science ®Google Scholar
• Qiu S., Li L., Weeber E. J., May J. M. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res 2007; 85: 1046–56
   PubMed Web of Science ®Google Scholar
• Wang W. P., Iyo A. H., Miguel‐Hidalgo J., Regunathan S., Zhu M. Y. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res 2006; 1084: 210–6
   PubMed Web of Science ®Google Scholar
• Matsumoto A., Okada Y., Nakamichi M., Nakamura M., Toyama Y., Sobue G., et al. Disease progression of human SOD1 (G93A) transgenic ALS model rats. J Neurosci Res 2006; 83: 119–33
   PubMedGoogle Scholar
• Ravits J., Laurie P., Fan Y., Moore D. H. Implications of ALS focality: rostral‐caudal distribution of lower motor neuron loss post mortem. Neurology 2007; 68: 1576–82
   PubMed Web of Science ®Google Scholar